These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 326682)

  • 21. Cytotoxic action of spleen lymphocytes to simian virus 40-induced tumor cells.
    Egusa K
    Acta Med Okayama; 1973 Aug; 27(3):107-23. PubMed ID: 4357059
    [No Abstract]   [Full Text] [Related]  

  • 22. [Proceedings: Immunity exhibited against the transplanted neoplasms by the homologous neoplasm cells].
    Hosokawa M; Oikawa K; Imamura M; Nakayama M; Kobayashi M
    Hokkaido Igaku Zasshi; 1975 Jan; 50(1):81-2. PubMed ID: 1171066
    [No Abstract]   [Full Text] [Related]  

  • 23. Host response to tumor-associated fetal antigens: kinetics and components.
    Salinas FA
    J Natl Cancer Inst; 1976 Aug; 57(2):349-54. PubMed ID: 63559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Immune" RNA--a new model for the immunotherapy of cancer.
    Pilch YH
    Cancer Chemother Rep 3; 1973 Mar; 4(2):287-92. PubMed ID: 4729332
    [No Abstract]   [Full Text] [Related]  

  • 25. Demonstration of tumor-associated immunity with a leukocyte adherence inhibition (LAI) assay.
    Hellström I; Hellström KE; Shantz G
    Int J Cancer; 1976 Sep; 18(3):354-61. PubMed ID: 955746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour antigens and alloantigens. I. Relation of a rat tumour-specific antigen with normal alloantigens of the host strain.
    Bowen JG; Baldwin RW
    Int J Cancer; 1979 Jun; 23(6):826-32. PubMed ID: 89101
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer progression and monocyte inflammatory dysfunction: relationship to tumour excision and metastasis.
    Normann SJ; Schardt M; Sorkin E
    Int J Cancer; 1979 Jan; 23(1):110-3. PubMed ID: 759376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transplantation immunity to syngeneic tumors in WKA rats immunized with allogeneic cells.
    Kobayashi H; Hosokawa M; Oikawa T
    Transplant Proc; 1980 Mar; 12(1):156-9. PubMed ID: 6989056
    [No Abstract]   [Full Text] [Related]  

  • 29. [Induction of anti-tumor cell-mediated immunity by local irradiation against transplanted brain tumor (author's transl)].
    Suda K
    Nihon Geka Hokan; 1982 Jan; 51(1):59-69. PubMed ID: 6979988
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunogenicity and immunosensitivity of SV40-transformed cells with different oncogenic potentials.
    Stillström J
    Int J Cancer; 1973 Sep; 12(2):493-501. PubMed ID: 4365094
    [No Abstract]   [Full Text] [Related]  

  • 31. Multicellular tumour spheroids: a model for combined in vivo/in vitro assay of tumour immunity.
    Culo F; Yuhas JM; Ladman AJ
    Br J Cancer; 1980 Jan; 41(1):100-12. PubMed ID: 7362771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Dunning R3327 prostate adenocarcinoma in the Fischer-Copenhagen F1 rat: a useful model for immunological studies.
    Claflin AJ; McKinney EC; Fletcher MA
    Oncology; 1977; 34(3):105-9. PubMed ID: 917439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour specific and embryonic antigen expression of chemically induced rat tumours.
    Baldwin RW; Glaves D; Pimm MV; Vose BM
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):715-28. PubMed ID: 4340543
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum factor levels during the growth of rat hepatoma nodules in the lungs.
    Bowen JG; Baldwin RW
    Int J Cancer; 1976 Feb; 17(2):254-60. PubMed ID: 175030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 mice.
    Schirrmacher V
    Int J Cancer; 1979 Jul; 24(1):80-6. PubMed ID: 314423
    [No Abstract]   [Full Text] [Related]  

  • 36. [The "immunologic portrait" and tumorigenicity of neoplastic cells induced in mice by 3-methylcholanthrene].
    Iaroslavtseva OA; Viksler VKh; Lavrovskiĭ VA
    Eksp Onkol; 1988; 10(6):26-9. PubMed ID: 3243190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of T antigen by cells derived from a hamster tumour induced by adenovirus type 12.
    Vasconcelos-Costa J
    Int J Cancer; 1970 Jul; 6(1):24-30. PubMed ID: 4918837
    [No Abstract]   [Full Text] [Related]  

  • 38. Transfusion-induced T suppressor cell activity and experimental tumor growth.
    Lenhard V; Scholler P; Zeller W
    Transplant Proc; 1989 Feb; 21(1 Pt 1):580-3. PubMed ID: 2523151
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum antibody responses to an ascitic variant of rat hepatoma D23.
    Robins RA
    Br J Cancer; 1975 Jul; 32(1):21-7. PubMed ID: 169868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of macrophages in tumour immunity. II. Involvement of a macrophage cytophilic factor during syngeneic tumour growth inhibition.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):627-36. PubMed ID: 4563478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.